Latest / The Diagnostics & Lab Testing Business Brief
The Diagnostics & Lab Testing Business Brief — Sunday, November 1, 2026
The Diagnostics & Lab Testing Business Brief — Sunday, November 1, 2026
The business behind the tests. Today's developments shaping the diagnostics industry.
Gliolab, the Glioblastoma Foundation's CLIA-certified genomic testing laboratory, begins accepting patient samples: announced Oct 31, 2026 — the Durham, North Carolina laboratory's first test is Whole-Genome DNA Methylation Profiling using the Epignostix Classifier, measuring methylation at hundreds of thousands of sites to classify the tumor and confirm a glioblastoma diagnosis, with MGMT promoter methylation, class/subclass, and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.